We talk to Cardiologist Dr. Jonathan Davis, Director of the Heart Failure program from San Francisco General about goal directed medical therapy in heart failure with reduced ejection fraction (HFrEF). This is part 1 of 2 parts which will cover an overview of GDMT medications, and dive into Beta-blockers and ARNIs. Part 2 to come out next week!

| 00.34 - Introduction |

| 01.55 - Consult Q: GDMT for HF |

Heart failure outcomes

| 05.20 - GDMT medication summary and overview |

| 07.17 - Effect on blood pressure and relative risk reduction for each drug |

| 10.59 - What order to start in |

Hint: ALL AT ONCE… if you can

| 11.53 - Beta-blockers |

When not to start (new HF in VOL), and when to re/start (almost all other times)
Tartrate vs Succinate: duration of action

| 15.40 - ARNI (Sacubitril-Valsartan) |

Potent natriuresis effect
Balancing the orthostatics

| 20.37 - Outro |

[The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.]

Music by Amit Apte. Medical Heart Vectors by Vecteezy